ARMP

Armata Pharmaceuticals, Inc. ARMP

NYSESmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Net income

$74.14M

Quarter to Jun 30

Free cash flow

$-8.68M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$32.29M total
Madison Asset Management, LLC
$13.65M0.0%
BlackRock, Inc.
$3.63M+760.9%
VANGUARD CAPITAL MANAGEMENT LLC
$3.16M+33.3%
MILLENNIUM MANAGEMENT LLC
$3.05M+82.4%
GEODE CAPITAL MANAGEMENT, LLC
$1.75M+136.2%
Dauntless Investment Group, LLC
$1.32M+125.1%
STATE STREET CORP
$839.8K+155.1%
NORTHERN TRUST CORP
$581.8K+264.3%
VANGUARD PORTFOLIO MANAGEMENT LLC
$527.2KNew
EDGEWOOD MANAGEMENT LLC
$518.4K-20.0%
VANGUARD FIDUCIARY TRUST CO
$515.1K+17.1%
Grey Ledge Advisors, LLC
$324.0K+66.7%
RENAISSANCE TECHNOLOGIES LLC
$313.1K+25.5%
BRIDGEWAY CAPITAL MANAGEMENT, LLC
$289.5K0.0%
SeaCrest Wealth Management, LLC
$269.1K0.0%
Bank of New York Mellon Corp
$192.8KNew
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
$187.0KNew
Hudson Bay Capital Management LP
$113.9K0.0%
Nuveen, LLC
$103.1KNew
NEW YORK STATE COMMON RETIREMENT FUND
$99.8KNew
UBS Group AG
$88.8K+214.9%
CAPTRUST FINANCIAL ADVISORS
$85.1K0.0%
DEUTSCHE BANK AG\
$77.5KNew
BANK OF AMERICA CORP /DE/
$73.3K-3.5%
XTX Topco Ltd
$70.2KNew
See all 53 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/ARMP

Earnings Per Share

13fpro.ai/company/ARMP

Loading ratio trend…

ARMP insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Armata Pharmaceuticals, Inc. (ARMP): stock profile, AI score and financials

Armata Pharmaceuticals, Inc. (ARMP) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. ARMP is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (Q2 2026), Armata Pharmaceuticals, Inc. reports net income of $74.1M, free cash flow of $-8.7M. Top institutional holders of ARMP by reported 13-F value include Madison Asset Management, BlackRock, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. ARMP trades on the NYSE exchange and files with the SEC under CIK 921114. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ARMP daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Armata Pharmaceuticals, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 921114 →